A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2) Conditions: NonSegmental Vitiligo Interventions: Drug: Povorcitinib; Drug: Placebo Sponsors: Incyte Corporation Recruiting Author:
